159 related articles for article (PubMed ID: 35794782)
21. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
22. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
23. [Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].
Tang J; Ke J; Fu Y; He XW; Li XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):577-583. PubMed ID: 34821087
[No Abstract] [Full Text] [Related]
24. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
25. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
26. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
27. NecroX-5 ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3-mediated epithelial-mesenchymal transition.
Min L; Shu-Li Z; Feng Y; Han H; Shao-Jun L; Sheng-Xiong T; Jia-Yu T; Xiang-Zhi F; Dan F
Respir Res; 2022 May; 23(1):128. PubMed ID: 35596212
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
29. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
31. β-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb/p65 phosphorylation and epithelial-mesenchymal transition.
Cui Y; Jiang L; Yu R; Shao Y; Mei L; Tao Y
J Ethnopharmacol; 2019 Oct; 243():112096. PubMed ID: 31323300
[TBL] [Abstract][Full Text] [Related]
32. Exercise training ameliorates bleomycin-induced epithelial mesenchymal transition and lung fibrosis through restoration of H
Du SF; Wang XL; Ye CL; He ZJ; Li DX; Du BR; Liu YJ; Zhu XY
Acta Physiol (Oxf); 2019 Feb; 225(2):e13177. PubMed ID: 30136377
[TBL] [Abstract][Full Text] [Related]
33. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4/NF-κB and TGF-β1/smad3 signalling pathways in rats.
Wang L; Shao M; Jiang W; Huang Y
Tissue Cell; 2022 Dec; 79():101953. PubMed ID: 36228366
[TBL] [Abstract][Full Text] [Related]
35. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
36. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT).
Rong L; Wu J; Wang W; Zhao RP; Xu XW; Hu D
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2144-50. PubMed ID: 27249616
[TBL] [Abstract][Full Text] [Related]
37. Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition.
Zhang LM; Zhang Y; Fei C; Zhang J; Wang L; Yi ZW; Gao G
Biochem Biophys Res Commun; 2019 Jan; 508(2):660-666. PubMed ID: 30527805
[TBL] [Abstract][Full Text] [Related]
38. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway.
Liu X; Shao Y; Zhang X; Ji X; Xie M; Liu H
Acta Histochem; 2021 Jul; 123(5):151746. PubMed ID: 34217047
[TBL] [Abstract][Full Text] [Related]
39. Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways.
Wanas H; El Shereef Z; Rashed L; Aboulhoda BE
Curr Mol Pharmacol; 2022; 15(1):227-238. PubMed ID: 33563204
[TBL] [Abstract][Full Text] [Related]
40. Chlorogenic Acid Inhibited Epithelial-Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy.
Mao X; Xie X; Ma J; Wei Y; Huang Z; Wang T; Zhu J; Wang Y; Zhao H; Hua J
Biol Pharm Bull; 2023; 46(7):929-938. PubMed ID: 37394644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
